Plus Therapeutics Inc
XBER:XMPA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Plus Therapeutics Inc
XBER:XMPA
|
US |
Intrinsic Value
The intrinsic value for
Plus Therapeutics Inc (XMPA) under the Base Case is 1.572 EUR.
Compared with the current market price of 0.206 EUR, the stock appears
Undervalued by 87% .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Plus Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Plus Therapeutics Inc
Earnings Waterfall
Plus Therapeutics Inc
The intrinsic value for
Plus Therapeutics Inc (XMPA) under the Base Case is 1.572 EUR.
Compared with the current market price of 0.206 EUR, the stock appears Undervalued by 87% .